Paul Herrling
#12,096
Most Influential Person Now
Academic
Paul Herrling's AcademicInfluence.com Rankings
Download Badge
Chemistry
Paul Herrling's Degrees
- PhD Chemistry University of Basel
Why Is Paul Herrling Influential?
(Suggest an Edit or Addition)According to Wikipedia, Paul Herrling is the head of corporate research at Novartis and the chairman of board of the Novartis Institute for Tropical Diseases, Singapore since 2002. Prior to this, he was the head of Global Research of Novartis Pharma.
Paul Herrling's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- CPP, a new potent and selective NMDA antagonist. Depression of central neuron responses, affinity for [3H]d-AP5 binding sites on brain membranes and anticonvulsant activity (1986) (302)
- Pharmacology of the corticocaudate excitatory postsynaptic potential in the cat: Evidence for its mediation by quisqualateor kainate-receptors (1985) (205)
- Iontophoretically applied dopamine depolarizes and hyperpolarizes the membrane of cat caudate neurons (1980) (173)
- Anticonvulsant activity of Mimosa pudica decoction. (2004) (142)
- In vitro release and electrophysiological effects in situ of homocysteic acid, an endogenous N-methyl-(D)-aspartic acid agonist, in the mammalian striatum (1986) (138)
- Anticonvulsant properties of the methanolic extract of Cyperus articulatus (Cyperaceae). (2001) (137)
- Synthesis and NMD A Antagonistic Properties of the Enantiomers of 4‐(3‐phosphonopropyl)piperazine‐2‐carboxylic acid (CPP) and of the unsaturated analogue (E)‐4‐(3‐phosphonoprop‐2‐enyl)piperazine‐2‐carboxylic acid (CPP‐ene) (1989) (90)
- Muscle relaxant and anticonvulsant activity of 3-((±)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid, a novel N-methyl-d-aspartate antagonist, in rodents (1987) (65)
- The membrane potential of cat hippocampal neurons recorded in vivo displays four different reaction-mechanisms to iontophoretically applied transmitter agonists (1981) (61)
- THE EFFECT OF BROMOCRIPTINE ON RAT STRIATAL ADENYLATE CYCLASE AND RAT BRAIN MONOAMINE METABOLISM (1978) (53)
- Excitatory amino acids : clinical results with antagonists (1997) (49)
- List of Drugs in Development for Neurodegenerative Diseases (2004) (42)
- Progress and potential for gene-based medicines. (2000) (39)
- Release of neuroactive substances: homocysteic acid as an endogenous agonist of the NMDA receptor (2005) (38)
- Trends in Modern Drug Discovery. (2015) (38)
- Synthesis and N‐Methyl‐D‐aspartate (NMDA) Antagonist Properties of the Enantiomers of α‐Amino‐5‐(phosphonomethyl)[1,1′‐biphenyl]‐3‐propanoic Acid. Use of a New Chiral Glycine Derivative (1992) (35)
- d-CPPene (SDZ EAA-494)—A Competitive NMDA Antagonist: Pharmacology and Results in Humans (1997) (28)
- The Foundation for the National Institutes of Health Biomarkers Consortium: Past Accomplishments and New Strategic Direction (2019) (28)
- Synthesis and NMDA Antagonistic Properties of the Enantiomers of 4-(3-Phosphonopropyl)piperazine-2-carboxylic Acid (CPP) and of the Unsaturated Analogue (E)-4-(3-Phosphonoprop-2-enyl)piperazine-2-carboxylic Acid (CPP-ene). (1989) (27)
- 6,7-Dichloro-3-hydroxy-2-quinoxalinecarboxylic acid is a relatively potent antagonist at NMDA and kainate receptors (1988) (23)
- Extracts from rhizomes of Cyperus articulatus (Cyperaceae) displace [3H]CGP39653 and [3H]glycine binding from cortical membranes and selectively inhibit NMDA receptor-mediated neurotransmission. (1996) (22)
- The drug discovery process. (2005) (22)
- Differential effects of (d)- and (l)-homocysteic acid on the membrane potential of cat caudate neurons in situ (1989) (19)
- List of Drugs in Development for Neurodegenerative Diseases: Update June 2009 (2009) (19)
- Clinical implications of NMDA receptors (1995) (19)
- Effects of opioid peptides on synaptic potentials in explants of rat hippocampus (1981) (17)
- Financing R&D for neglected diseases (2009) (17)
- Setting Our Sights on Infectious Diseases (2019) (17)
- Effects ofl-cysteine-sulphinate andl-aspartate, mixed excitatory amino acid agonists, on the membrane potential of cat caudate neurons (1987) (16)
- Effects of Cyperus articulatus compared to effects of anticonvulsant compounds on the cortical wedge. (2003) (15)
- Zebrafish bioassay-guided isolation of antiseizure compounds from the Cameroonian medicinal plant Cyperus articulatus L. (2020) (14)
- Maximizing pharmaceutical research by collaboration (1998) (14)
- Homocysteic acid, an endogenous agonist of NMDA-receptor: release, neuroactivity and localization. (1986) (13)
- List of Drugs in Development for Neurodegenerative Diseases (2005) (12)
- List of Drugs in Development for Neurodegenerative Diseases (2006) (12)
- Neural Plasticity and Repair (2007) (12)
- Homocysteic acid as transmitter candidate in the mammalian brain and excitatory amino acids in epilepsy. (1990) (11)
- Synaptic physiology of excitatory amino acids. (1992) (11)
- Experiments in social responsibility (2006) (10)
- Progress and Potential for Gene-Based (2000) (10)
- List of Drugs in Development for Neurodegenerative Diseases (2007) (8)
- N-methyl-d-aspartate induces regular firing patterns in the cat lateral habenula in vivo (1993) (7)
- Two Types of Excitatory Amino Acid Responses in the Cat Caudate Nucleus (1983) (7)
- Patent sense (2007) (6)
- Mechanism of action of atypical antipsychotics. (1991) (5)
- 2623 – BROMOCRIPTINE MIMICS DOPAMINE EFFECTS ON THE CYCLIC AMP SYSTEM OF RAT PITUITARY GLAND (1978) (4)
- Effects of clozapine in a selective muscarinic bioassay and on single cells of the rat hippocampus (1982) (4)
- List of Drugs in Development for Neurodegenerative Diseases: Update June 2010 (2010) (4)
- Biochemical and pharmacological effects of fluperlapine on noradrenaline and acetylcholine systems in some rodent, bovine and crustacean preparations (1986) (3)
- Evidence for GABA as the transmitter for early cortically evoked inhibition of cat caudate neurons (2004) (3)
- Synthesis and N‐Methyl‐D‐aspartate (NMDA) Antagonist Properties of the Enantiomers of α‐Amino‐5‐(phosphonomethyl)(1,1′‐biphenyl)‐3‐ propanoic Acid. Use of a New Chiral Glycine Derivative. (1992) (3)
- Modulation of Synaptic Potentials in situ by Specific Agonists of Excitatory Amino Acids (1987) (2)
- List of Drugs in Development for Neurodegenerative Diseases (2004) (2)
- Drug Discovery for Neglected Diseases of the Developing World (2010) (2)
- CD-ROM instruction : a generic approach (1991) (2)
- List of Drugs in Development for Neurodegenerative Diseases (2008) (1)
- List of Drugs in Development for Neurodegenerative Diseases (2005) (1)
- Ize : the all-terrain vehicle of database managers (1990) (1)
- Vision : Taking aim at neglected diseases (2005) (1)
- Preface (2007) (0)
- Building a competitive functional genomics platform (1999) (0)
- [First success of research. Soon a drug against dengue fever?]. (2007) (0)
- Subject Index Vol. 1, 2004 (2005) (0)
- Substituted (alpha) -amino acids, process for their preparation and pharmaceutical compositions containing them (1985) (0)
- [Stimulating chemical transmitter systems in the brain]. (1986) (0)
- substituted amino acids (1987) (0)
- Summary Table of Compounds and Their Clinical Status (1997) (0)
- Contents Vol. 1, 2004 (2005) (0)
- New a-substituted amino acids, their preparation and their use as therapeutic drugs (1987) (0)
- In situ situation (1992) (0)
- Subject Index Vol. 4, 2007 (2007) (0)
- A-substituted amino acids, their manufacture and pharmaceutical compositions containing them (1985) (0)
- An audience with... Paul Herrling. Interview by Joanna Owens. (2007) (0)
- Substituted alpha-amino acid, preparation of the same and drug (1990) (0)
- From genome to therapy: industry perspective. (2000) (0)
- Novel substituted a-aminoacids, their preparation and their use in therapeutics as medicaments (1987) (0)
- Contents Vol. 4, 2007 (2007) (0)
This paper list is powered by the following services:
Other Resources About Paul Herrling
What Schools Are Affiliated With Paul Herrling?
Paul Herrling is affiliated with the following schools:
